The scientist’s investigation covers issues in Immunology, Internal medicine, Immunotherapy, Molecular biology and Myeloid leukemia. Immune system and Dendritic cell are the subjects of his Immunology studies. He has included themes like Cancer research, Genetic enhancement and Antigen-presenting cell in his Dendritic cell study.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology. His Molecular biology research is multidisciplinary, incorporating perspectives in Virology, Immunoglobulin superfamily, Roseolovirus, Electroporation and Bone marrow. Zwi N. Berneman usually deals with Myeloid leukemia and limits it to topics linked to Leukemia and Myeloid, Imatinib mesylate and Case-control study.
His scientific interests lie mostly in Immunology, Internal medicine, Immune system, Molecular biology and Dendritic cell. His study in Immunology concentrates on Immunotherapy, Antigen, T cell, Vaccination and Multiple sclerosis. Zwi N. Berneman works on Internal medicine which deals in particular with Myeloid leukemia.
His Immune system study incorporates themes from Cancer and Interleukin 15. His Molecular biology research integrates issues from Cell culture, Haematopoiesis, Virology, Electroporation and Bone marrow. The various areas that Zwi N. Berneman examines in his Dendritic cell study include Cancer research and Antigen-presenting cell.
Zwi N. Berneman mainly investigates Immunology, Immune system, Internal medicine, Multiple sclerosis and T cell. The concepts of his Immunology study are interwoven with issues in Cell therapy, Cellular differentiation and Transplantation. His work in Immune system addresses issues such as Cancer research, which are connected to fields such as Cell.
His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine. His T-cell receptor study also includes fields such as
Zwi N. Berneman mostly deals with Immunology, T cell, Immune system, Multiple sclerosis and Dendritic cell. His work carried out in the field of Immunology brings together such families of science as Stimulation and Exercise physiology. The study incorporates disciplines such as Cytotoxic T cell, Interleukin 15 and CD8 in addition to T cell.
His Immune system research is multidisciplinary, relying on both Cancer research, Stem cell, Transplantation and Central nervous system. His biological study spans a wide range of topics, including Internal medicine, Oncology and Immunotherapy. Zwi N. Berneman interconnects Electroporation and Cell biology in the investigation of issues within RNA transfection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Katrien Vermeulen;Dirk R. Van Bockstaele;Zwi N. Berneman.
Cell Proliferation (2003)
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
Viggo F. I. Van Tendeloo;Peter Ponsaerts;Filip Lardon;Griet Nijs.
Blood (2001)
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
Lucien Noens;Marie Anne Van Lierde;Robrecht De Bock;Gregor Verhoef.
Blood (2009)
Cell cycle and apoptosis.
Katrien Vermeulen;Zwi N. Berneman;Dirk R. Van Bockstaele.
Cell Proliferation (2003)
Apoptosis: mechanisms and relevance in cancer.
Katrien Vermeulen;Dirk R. Van Bockstaele;Zwi N. Berneman.
Annals of Hematology (2005)
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
B. Löwenberg;S. Suciu;E. Archimbaud;H. Haak.
Journal of Clinical Oncology (1998)
Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo
Thierry VandenDriessche;Lieven Thorrez;Luigi Naldini;Antonia Follenzi.
Blood (2002)
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells
Nathalie Cools;Peter Ponsaerts;Viggo F. I. Van Tendeloo;Zwi N. Berneman.
Journal of Leukocyte Biology (2007)
Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)
B. Lowenberg;S. Suciu;E. Archimbaud;G.J. Ossenkoppele.
Blood (1997)
Regulatory T cells and human disease.
Nathalie Cools;Peter Ponsaerts;Viggo F. I. Van Tendeloo;Zwi N. Berneman.
Clinical & Developmental Immunology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Antwerp
University of Antwerp
University of Antwerp
European Organisation for Research and Treatment of Cancer
Osaka University
KU Leuven
Radboud University Nijmegen
University of Antwerp
University of Rome Tor Vergata
University of Ferrara
University of Cambridge
University of Chicago
Microsoft (United States)
Virginia Tech
Leiden University
Oregon Health & Science University
Utrecht University
University of South Florida
National Taiwan University
Université Paris Cité
University of Tübingen
Chinese Academy of Sciences
University of Porto
University of Florence
University of Amsterdam
Florida State University